A312 POST MARKET USE OF TEDUGLUTIDE IN CANADA IN PATIENTS WITH SHORT BOWEL SYNDROME ON HOME PARENTERAL NUTRITION: THE REAL WORLD SETTING

BACKGROUND: Patients with intestinal failure due to short bowel syndrome (SBS) are dependent on parenteral support (PS). Teduglutide, a glucagon-like peptide-2 (GLP-2) agonist, can reduce PS requirement by enhancing absorptive capacity of the remaining intestine. As it was only approved for use in C...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Can Assoc Gastroenterol
Autori principali: Noelting, J, Jurewitsch, B, Gramlich, L, Duerksen, D, Raman, M, Armstrong, D, Ponta, M L, Saqui, O, Arca-Juico, C K, Kim, P, Stewart, B, Allard, J
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Paper Sessions
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6508186/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.312
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi